Paylocity reported earnings on August 6 against a backdrop of sharply bullish options positioning — and the analyst community wasted no time responding.
Three firms raised price targets within hours of the print. BTIG lifted its target to $180 from $150, maintaining Buy. Cantor Fitzgerald moved to $165 from $140, also holding Overweight. Keybanc raised to $178 from $172, keeping its Overweight rating. All three actions arrived on August 5, making this one of the most concentrated post-earnings target-lift clusters the stock has seen. The Street's mean target now sits at $170.74, roughly 19% above Tuesday's close of $143.32. The lone holdout remains UBS, which raised its Neutral target to $128 in late July — still well below the current price, signalling the bears on the Street see the 25% one-month rally as having run ahead of fundamentals.
The options market had called this outcome early. The put/call ratio dropped to 0.32 heading into the print — nearly two standard deviations below its 20-day average of 0.54, and among the most call-heavy readings of the past year. That bullish tilt proved correct. The PCR has barely budged post-earnings, holding near 0.32, suggesting options traders are not rotating into defensive positioning after the move. The prior earnings event, in May, produced an 8.2% one-day gain — the stock has now strung together two consecutive positive reactions.
Short interest tells a quieter story. At 5.5% of free float, the short position is meaningful but has barely moved — down less than 1% on the week and roughly flat over the past month. Shorts did not pile in ahead of earnings, and they have not rushed to cover into the rally. The borrow market remains entirely relaxed: availability is effectively uncapped at over 44 million shares available against fewer than 3 million short. Cost to borrow has crept up about 29% on the week to 0.50%, but remains negligible in absolute terms. There is no squeeze dynamic here — the move is fundamental, not mechanical.
Institutional positioning reflects genuine conviction in the name. T. Rowe Price holds 8.7% of shares, BlackRock 8.2%, and both added to positions through June. Geode Capital added roughly 151,000 shares in the same period. Insider activity over the past 90 days has been uniformly sell-side — the CFO and Executive Chairman among those reducing — though all trades were small relative to their holdings and at prices well below current levels, making them routine rather than alarming. The net insider value sold over 90 days was approximately $1.8 million, modest for a company of this size.
The EV/EBITDA multiple has compressed slightly over the past month to 9.9x, while the PE has expanded to 14.9x as the stock ran. The 90-day EPS momentum factor rank sits at the 92nd percentile — one of the stronger readings across the coverage universe — while the analyst recommendation divergence factor ranks at just the 2nd percentile, flagging that consensus is tight and upgrades from the sideline holdouts (UBS, Barclays) remain the clearest remaining catalyst. Among peers, PAYC had a strong week too, up 8.4%, while PAYX was flat and ADP added 2.4% — suggesting the post-earnings lift was PCTY-specific rather than a broad HCM sector bid.
The key question now is whether UBS and Barclays, both sitting well below the current price on Neutral and Equal-Weight ratings, revise their views in the days ahead — and whether the PCR holds near its current lows or begins to rebuild as the post-earnings euphoria fades.
See the live data behind this article on ORTEX.
Open PCTY on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
